After finishing sixth in the AL with a 2.92 ERA in 2011, Ricky Romero endured a nightmare campaign last year in which he struggled to the tune of a 5.77 ERA and 124/105 K/BB ratio over 181 innings. While the drop-off was alarming, it was somewhat explained when the southpaw had an elbow cleanup in October and received platelet-rich plasma injections in both of his knees. Now he’s hoping for a big bounce back year.
According to Gregor Chisholm of MLB.com, Romero threw off a mound several times before reporting to Jays’ camp and can already feel the difference with his elbow.
“It feels 100 times better,” said Romero, who avoided the DL in 2012. “I wasn’t able to rotate [the elbow] at one point, I was so sore at the end of the year. That’s when I decided we should get it checked out. Right now, it feels great, pretty much back to how it should feel.
“The knees have been a work in progress. I think that’s been the toughest part, that tendinitis doesn’t go away easily. We’ve been hitting it hard every day, I’m here getting treatment, doing the small things, foam-rolling, stuff like that, just to kind of get them ready every day.”
Encouraging news for a team who clearly sees an opening in the AL East. The Blue Jays strengthened their rotation over the winter by adding R.A. Dickey, Josh Johnson and Mark Buehrle, but getting a healthy and effective Romero back would be the equivalent of another significant offseason addition.
Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.
Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.
The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.
It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.
The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.
Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.